Dennis Lo | Academic Influence

Q: What Schools Are Affiliated With Dennis Lo

Dennis Lo is affiliated with the following schools: University of Oxford, Chinese University of Hong Kong, University of Cambridge

Dennis Lo's Degrees

PhD Chemical Pathology Chinese University of Hong Kong

Why Is Dennis Lo Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Dennis Yuk Ming Lo is a Hong Kong molecular biologist, and an important contributor to the development of non-invasive prenatal testing. He is the current Associate Dean and Li Ka Shing Professor of Medicine at the Chinese University of Hong Kong , as well as the head of the Department of Chemical Pathology of CUHK and the director of the Li Ka Shing Institute of Health Sciences. His research focuses on the detection of cell-free fetal DNA in blood plasma.

(See a Problem?)

Dennis Lo's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Presence of fetal DNA in maternal plasma and serum (1997) (2727)
Quantitative analysis of fetal DNA in maternal plasma and serum: implications for noninvasive prenatal diagnosis. (1998) (1642)
Rapid clearance of fetal DNA from maternal plasma. (1999) (1087)
Maternal Plasma DNA Sequencing Reveals the Genome-Wide Genetic and Mutational Profile of the Fetus (2010) (870)
Noninvasive prenatal diagnosis of fetal chromosomal aneuploidy by massively parallel genomic sequencing of DNA in maternal plasma (2008) (853)
Detection and characterization of placental microRNAs in maternal plasma. (2008) (813)
Quantitative analysis of cell-free Epstein-Barr virus DNA in plasma of patients with nasopharyngeal carcinoma. (1999) (738)
Prenatal diagnosis of fetal RhD status by molecular analysis of maternal plasma. (1998) (732)
Non-invasive prenatal assessment of trisomy 21 by multiplexed maternal plasma DNA sequencing: large scale validity study (2011) (592)
Molecular Evolution of the SARS Coronavirus During the Course of the SARS Epidemic in China (2004) (590)
Molecular Evolution of the SARS Coronavirus During the Course of the SARS Epidemic in China (2004) (590)
Size distributions of maternal and fetal DNA in maternal plasma. (2004) (555)
Stability of endogenous and added RNA in blood specimens, serum, and plasma. (2002) (541)
Detection of aberrant p16 methylation in the plasma and serum of liver cancer patients. (1999) (523)
Lengthening and shortening of plasma DNA in hepatocellular carcinoma patients (2015) (503)
Quantitative abnormalities of fetal DNA in maternal serum in preeclampsia. (1999) (496)
Predominant hematopoietic origin of cell-free DNA in plasma and serum after sex-mismatched bone marrow transplantation. (2002) (476)
Cancer genome scanning in plasma: detection of tumor-associated copy number aberrations, single-nucleotide variants, and tumoral heterogeneity by massively parallel sequencing. (2013) (444)
Analysis of Plasma Epstein–Barr Virus DNA to Screen for Nasopharyngeal Cancer (2017) (436)
mRNA of placental origin is readily detectable in maternal plasma (2003) (411)
Microfluidics digital PCR reveals a higher than expected fraction of fetal DNA in maternal plasma. (2008) (410)
Plasma placental RNA allelic ratio permits noninvasive prenatal chromosomal aneuploidy detection (2007) (405)
Quantitative and temporal correlation between circulating cell-free Epstein-Barr virus DNA and tumor recurrence in nasopharyngeal carcinoma. (1999) (399)
Plasma Epstein-Barr virus DNA and residual disease after radiotherapy for undifferentiated nasopharyngeal carcinoma. (2002) (385)
Single-Molecule Detection of Epidermal Growth Factor Receptor Mutations in Plasma by Microfluidics Digital PCR in Non–Small Cell Lung Cancer Patients (2009) (372)
Plasma DNA as a prognostic marker in trauma patients. (2000) (369)
Digital PCR for the molecular detection of fetal chromosomal aneuploidy (2007) (354)
Effects of blood-processing protocols on fetal and total DNA quantification in maternal plasma. (2001) (350)
Hypermethylated RASSF1A in maternal plasma: A universal fetal DNA marker that improves the reliability of noninvasive prenatal diagnosis. (2006) (350)
Detection of the placental epigenetic signature of the maspin gene in maternal plasma. (2005) (342)
Molecular prognostication of nasopharyngeal carcinoma by quantitative analysis of circulating Epstein-Barr virus DNA. (2000) (324)
Noninvasive detection of cancer-associated genome-wide hypomethylation and copy number aberrations by plasma DNA bisulfite sequencing (2013) (323)
Plasma Epstein-Barr viral deoxyribonucleic acid quantitation complements tumor-node-metastasis staging prognostication in nasopharyngeal carcinoma. (2006) (321)
Increased fetal DNA concentrations in the plasma of pregnant women carrying fetuses with trisomy 21. (1999) (317)
Presence of fetal RNA in maternal plasma. (2000) (295)
Noninvasive Prenatal Diagnosis of Fetal Trisomy 18 and Trisomy 13 by Maternal Plasma DNA Sequencing (2011) (287)
Prognostic use of circulating plasma nucleic acid concentrations in patients with acute stroke. (2003) (280)
Presence of filterable and nonfilterable mRNA in the plasma of cancer patients and healthy individuals. (2002) (278)
Noninvasive prenatal diagnosis of monogenic diseases by digital size selection and relative mutation dosage on DNA in maternal plasma (2008) (261)
Maternal plasma fetal DNA as a marker for preterm labour (1998) (258)
Quantitative analysis of the bidirectional fetomaternal transfer of nucleated cells and plasma DNA. (2000) (257)
Presence of donor-specific DNA in plasma of kidney and liver-transplant recipients (1998) (255)
Prenatal exclusion of β thalassaemia major by examination of maternal plasma (2002) (243)
Noninvasive prenatal diagnosis of hemophilia by microfluidics digital PCR analysis of maternal plasma DNA. (2011) (231)
Detection of SARS Coronavirus RNA in the Cerebrospinal Fluid of a Patient with Severe Acute Respiratory Syndrome (2003) (230)
Molecular characterization of circulating EBV DNA in the plasma of nasopharyngeal carcinoma and lymphoma patients. (2003) (228)
The Long and Short of Circulating Cell-Free DNA and the Ins and Outs of Molecular Diagnostics. (2016) (228)
Increased maternal plasma fetal DNA concentrations in women who eventually develop preeclampsia. (2001) (227)
Size-based molecular diagnostics using plasma DNA for noninvasive prenatal testing (2014) (223)
Quantitative analysis of aberrant p16 methylation using real-time quantitative methylation-specific polymerase chain reaction. (1999) (221)
Circulating nucleic acids in plasma/serum (2007) (209)
MS analysis of single-nucleotide differences in circulating nucleic acids: Application to noninvasive prenatal diagnosis. (2004) (208)
Noninvasive prenatal diagnosis of congenital adrenal hyperplasia using cell-free fetal DNA in maternal plasma. (2014) (208)
Early diagnosis of SARS Coronavirus infection by real time RT-PCR (2003) (205)
Differential DNA methylation between fetus and mother as a strategy for detecting fetal DNA in maternal plasma. (2002) (201)
Quantitative analysis of circulating mitochondrial DNA in plasma. (2003) (201)
Integrative single-cell and cell-free plasma RNA transcriptomics elucidates placental cellular dynamics (2017) (199)
Kinetics of plasma Epstein-Barr virus DNA during radiation therapy for nasopharyngeal carcinoma. (2000) (197)
Time course of early and late changes in plasma DNA in trauma patients. (2003) (194)
High-resolution profiling of fetal DNA clearance from maternal plasma by massively parallel sequencing. (2013) (187)
Frequent p15 promoter methylation in tumor and peripheral blood from hepatocellular carcinoma patients. (2000) (179)
Diagnostic developments involving cell-free (circulating) nucleic acids. (2006) (178)
Male microchimerism in healthy women and women with scleroderma: cells or circulating DNA? A quantitative answer. (2002) (178)
Plasma Epstein-Barr viral DNA load at midpoint of radiotherapy course predicts outcome in advanced-stage nasopharyngeal carcinoma. (2014) (176)
Analysis of cell-free Epstein-Barr virus associated RNA in the plasma of patients with nasopharyngeal carcinoma. (1999) (175)
Silencing of GSTP1 gene by CpG island DNA hypermethylation in HBV-associated hepatocellular carcinomas. (2002) (175)
Effects of preanalytical factors on the molecular size of cell-free DNA in blood. (2005) (175)
Noninvasive prenatal detection of fetal trisomy 18 by epigenetic allelic ratio analysis in maternal plasma: Theoretical and empirical considerations. (2006) (174)
The concentration of circulating corticotropin-releasing hormone mRNA in maternal plasma is increased in preeclampsia. (2003) (167)
EDTA is a better anticoagulant than heparin or citrate for delayed blood processing for plasma DNA analysis. (2004) (166)
Rapid clearance of plasma Epstein-Barr virus DNA after surgical treatment of nasopharyngeal carcinoma. (2003) (161)
Quantitative Analysis and Prognostic Implication of SARS Coronavirus RNA in the Plasma and Serum of Patients with Severe Acute Respiratory Syndrome (2003) (159)
Noninvasive prenatal diagnosis of monogenic diseases by targeted massively parallel sequencing of maternal plasma: application to β-thalassemia. (2012) (151)
The 3a protein of severe acute respiratory syndrome-associated coronavirus induces apoptosis in Vero E6 cells. (2005) (151)
Plasma nucleic acids in the diagnosis and management of malignant disease. (2002) (151)
Pretherapy quantitative measurement of circulating Epstein–Barr virus DNA is predictive of posttherapy distant failure in patients with early‐stage nasopharyngeal carcinoma of undifferentiated type (2003) (148)
Early detection of nasopharyngeal carcinoma by plasma Epstein‐Barr virus DNA analysis in a surveillance program (2013) (147)
Quantitative analysis of circulating methylated DNA as a biomarker for hepatocellular carcinoma. (2008) (147)
Analysis of Plasma Epstein-Barr Virus DNA in Nasopharyngeal Cancer After Chemoradiation to Identify High-Risk Patients for Adjuvant Chemotherapy: A Randomized Controlled Trial. (2018) (144)
Hypermethylation of RASSF1A in human and rhesus placentas. (2007) (141)
Noninvasive prenatal exclusion of congenital adrenal hyperplasia by maternal plasma analysis: a feasibility study. (2002) (140)
Fetal DNA in maternal plasma: biology and diagnostic applications. (2000) (140)
Epigenetics, fragmentomics, and topology of cell-free DNA in liquid biopsies (2021) (139)
Fetal DNA clearance from maternal plasma is impaired in preeclampsia. (2002) (137)
Missense glucokinase mutation in maturity–onset diabetes of the young and mutation screening in late–onset diabetes (1992) (136)
Innovations: Prenatal diagnosis: progress through plasma nucleic acids (2007) (136)
An International Collaboration to Harmonize the Quantitative Plasma Epstein-Barr Virus DNA Assay for Future Biomarker-Guided Trials in Nasopharyngeal Carcinoma (2013) (134)
Orientation-aware plasma cell-free DNA fragmentation analysis in open chromatin regions informs tissue of origin (2019) (133)
Noninvasive prenatal methylomic analysis by genomewide bisulfite sequencing of maternal plasma DNA. (2013) (132)
Systematic micro-array based identification of placental mRNA in maternal plasma: towards non-invasive prenatal gene expression profiling (2004) (132)
FALSE-POSITIVE RESULTS AND THE POLYMERASE CHAIN REACTION (1988) (130)
Prenatal exclusion of beta thalassaemia major by examination of maternal plasma. (2002) (129)
Quantitative analysis of circulating cell-free Epstein-Barr virus (EBV) DNA levels in patients with EBV-associated lymphoid malignancies. (2000) (129)
Second generation noninvasive fetal genome analysis reveals de novo mutations, single-base parental inheritance, and preferred DNA ends (2016) (129)
Cell-free DNA in serum and plasma: comparison of ELISA and quantitative PCR. (2005) (125)
Phase II study of neoadjuvant carboplatin and paclitaxel followed by radiotherapy and concurrent cisplatin in patients with locoregionally advanced nasopharyngeal carcinoma: therapeutic monitoring with plasma Epstein-Barr virus DNA. (2004) (123)
Prenatal diagnosis: progress through plasma nucleic acids. (2007) (122)
Preferred end coordinates and somatic variants as signatures of circulating tumor DNA associated with hepatocellular carcinoma (2018) (119)
Presence of donor- and recipient-derived DNA in cell-free urine samples of renal transplantation recipients: urinary DNA chimerism. (1999) (118)
Cell-free nucleic acids in plasma, serum and urine: a new tool in molecular diagnosis (2003) (117)
Targeted massively parallel sequencing of maternal plasma DNA permits efficient and unbiased detection of fetal alleles. (2011) (115)
Quantitation of circulating DNA in the serum of breast cancer patients by real-time PCR (2004) (115)
Improved accuracy of detection of nasopharyngeal carcinoma by combined application of circulating Epstein-Barr virus DNA and anti-Epstein-Barr viral capsid antigen IgA antibody. (2004) (113)
Diagnostic and prognostic implications of circulating cell-free Epstein-Barr virus DNA in natural killer/T-cell lymphoma. (2001) (112)
Quantitative analysis of tumor-derived methylated p16INK4a sequences in plasma, serum, and blood cells of hepatocellular carcinoma patients. (2003) (109)
Dnase1l3 deletion causes aberrations in length and end-motif frequencies in plasma DNA (2018) (108)
Systematic search for placental DNA-methylation markers on chromosome 21: toward a maternal plasma-based epigenetic test for fetal trisomy 21. (2008) (107)
Determination of RhD zygosity: comparison of a double amplification refractory mutation system approach and a multiplex real-time quantitative PCR approach. (2001) (106)
Maternal plasma DNA analysis with massively parallel sequencing by ligation for noninvasive prenatal diagnosis of trisomy 21. (2010) (105)
Noninvasive prenatal detection of trisomy 21 by an epigenetic-genetic chromosome-dosage approach. (2010) (105)
Relationship between pretreatment level of plasma Epstein-Barr virus DNA, tumor burden, and metabolic activity in advanced nasopharyngeal carcinoma. (2006) (104)
Quantification of Plasma β-Catenin mRNA in Colorectal Cancer and Adenoma Patients (2004) (103)
Non-invasive prenatal diagnosis by single molecule counting technologies. (2009) (101)
Fetal cell-free plasma DNA concentrations in maternal blood are stable 24 hours after collection: analysis of first- and third-trimester samples. (2003) (97)
Nonhematopoietically derived DNA is shorter than hematopoietically derived DNA in plasma: a transplantation model. (2012) (97)
Rapid production of vector-free biotinylated probes using the polymerase chain reaction. (1988) (96)
Maternal Plasma Fetal DNA Fractions in Pregnancies with Low and High Risks for Fetal Chromosomal Aneuploidies (2014) (96)
Size-tagged preferred ends in maternal plasma DNA shed light on the production mechanism and show utility in noninvasive prenatal testing (2018) (96)
Sequencing-based counting and size profiling of plasma Epstein–Barr virus DNA enhance population screening of nasopharyngeal carcinoma (2018) (95)
Plasma mitochondrial DNA concentrations after trauma. (2004) (91)
Circulating EBV DNA as a tumor marker for nasopharyngeal carcinoma. (2002) (90)
Plasma DNA aberrations in systemic lupus erythematosus revealed by genomic and methylomic sequencing (2014) (88)
Circulating Nucleic Acids in Plasma and Serum: An Overview (2001) (88)
Plasma DNA end motif profiling as a fragmentomic marker in cancer, pregnancy and transplantation. (2020) (85)
Plasma Cell‐free Epstein‐Barr Virus DNA Quantitation in Patients with Nasopharyngeal Carcinoma: Correlation with Clinical Staging (2000) (85)
Prenatal Diagnosis Innovation: Genome Sequencing of Maternal Plasma. (2016) (84)
High Resolution Size Analysis of Fetal DNA in the Urine of Pregnant Women by Paired-End Massively Parallel Sequencing (2012) (84)
Serum Proteomic Fingerprints of Adult Patients with Severe Acute Respiratory Syndrome (2006) (84)
Direct haplotype determination by double ARMS: specificity, sensitivity and genetic applications (1991) (84)
ACE2 Gene Polymorphisms Do Not Affect Outcome of Severe Acute Respiratory Syndrome (2004) (83)
Origin of plasma cell-free DNA after solid organ transplantation. (2003) (80)
Persistent Aberrations in Circulating DNA Integrity after Radiotherapy Are Associated with Poor Prognosis in Nasopharyngeal Carcinoma Patients (2008) (78)
Genomic analysis of fetal nucleic acids in maternal blood. (2012) (77)
Noninvasive twin zygosity assessment and aneuploidy detection by maternal plasma DNA sequencing (2013) (77)
Non-invasive prenatal diagnosis by fetal nucleic acid analysis in maternal plasma: the coming of age. (2011) (76)
Detection of fetal-derived paternally inherited X-chromosome polymorphisms in maternal plasma. (1999) (76)
Maternal plasma RNA sequencing for genome-wide transcriptomic profiling and identification of pregnancy-associated transcripts. (2014) (76)
Plasma cell-free DNA as an indicator of severity of injury in burn patients (2006) (75)
Universal Haplotype-Based Noninvasive Prenatal Testing for Single Gene Diseases. (2017) (74)
A phase II study of patients with metastatic or locoregionally recurrent nasopharyngeal carcinoma and evaluation of plasma Epstein–Barr virus DNA as a biomarker of efficacy (2008) (73)
Plasma DNA as a prognostic marker for stroke patients with negative neuroimaging within the first 24 h of symptom onset. (2006) (71)
In vitro amplification of hepatitis B virus sequences from liver tumour DNA and from paraffin wax embedded tissues using the polymerase chain reaction. (1989) (71)
Synergy of total PLAC4 RNA concentration and measurement of the RNA single-nucleotide polymorphism allelic ratio for the noninvasive prenatal detection of trisomy 21. (2010) (71)
Coronavirus genomic-sequence variations and the epidemiology of the severe acute respiratory syndrome. (2003) (71)
Noninvasive prenatal determination of twin zygosity by maternal plasma DNA analysis. (2013) (70)
Noninvasive Prenatal Molecular Karyotyping from Maternal Plasma (2013) (70)
Serial Analysis of the Plasma Concentration of SARS Coronavirus RNA in Pediatric Patients with Severe Acute Respiratory Syndrome (2003) (70)
Circulating tumour-derived nucleic acids in cancer patients: potential applications as tumour markers (2007) (68)
Genomic characterisation of the severe acute respiratory syndrome coronavirus of Amoy Gardens outbreak in Hong Kong (2003) (66)
Noninvasive Prenatal Diagnosis of Fetal Trisomy 21 by Allelic Ratio Analysis Using Targeted Massively Parallel Sequencing of Maternal Plasma DNA (2012) (66)
Prenatal detection of fetal Down's syndrome from maternal plasma (2000) (65)
Identification and characterization of extrachromosomal circular DNA in maternal plasma (2020) (64)
Circulating corticotropin-releasing hormone mRNA in maternal plasma: relationship with gestational age and severity of preeclampsia. (2004) (63)
Disparity of sensitivities in detection of radiation-naïve and postirradiation recurrent nasopharyngeal carcinoma of the undifferentiated type by quantitative analysis of circulating Epstein-Barr virus DNA1,2. (2003) (63)
Fetomaternal Cellular and Plasma DNA Trafficking (2001) (61)
Cell-free fetal deoxyribonucleic acid in maternal circulation as a marker of fetal-maternal hemorrhage in patients undergoing external cephalic version near term. (2000) (61)
FetalQuant: deducing fractional fetal DNA concentration from massively parallel sequencing of DNA in maternal plasma (2012) (60)
Fetal RhD genotyping from maternal plasma. (1999) (60)
Circulating placental RNA in maternal plasma is associated with a preponderance of 5' mRNA fragments: implications for noninvasive prenatal diagnosis and monitoring. (2005) (60)
The detection of the c-myc and ras oncogenes in nasopharyngeal carcinoma by immunohistochemistry. (1994) (60)
Noninvasive prenatal diagnosis of fetal chromosomal aneuploidies by maternal plasma nucleic acid analysis. (2008) (59)
Genome-wide expression analysis using microarray identified complex signaling pathways modulated by hypoxia in nasopharyngeal carcinoma. (2007) (59)
Lack of dramatic enrichment of fetal DNA in maternal plasma by formaldehyde treatment. (2005) (58)
Culture of fetal erythroid cells from maternal peripheral blood (1994) (57)
DNA of Erythroid Origin Is Present in Human Plasma and Informs the Types of Anemia. (2017) (57)
Genomewide bisulfite sequencing reveals the origin and time-dependent fragmentation of urinary cfDNA. (2017) (55)
Quantitative Analysis of the Transrenal Excretion of Circulating EBV DNA in Nasopharyngeal Carcinoma Patients (2008) (55)
Recent advances in fetal nucleic acids in maternal plasma. (2005) (55)
Liver- and Colon-Specific DNA Methylation Markers in Plasma for Investigation of Colorectal Cancers with or without Liver Metastases. (2018) (55)
Time profile of appearance and disappearance of circulating placenta-derived mRNA in maternal plasma. (2006) (55)
Noninvasive prenatal detection of fetal chromosomal aneuploidies by maternal plasma nucleic acid analysis: a review of the current state of the art (2009) (55)
Fifty years of molecular (DNA/RNA) diagnostics. (2005) (55)
Detection of circulating fetal nucleic acids: a review of methods and applications (2009) (53)
Circulating Epstein-Barr virus DNA in the serum of patients with gastric carcinoma. (2001) (52)
Methy-Pipe: An Integrated Bioinformatics Pipeline for Whole Genome Bisulfite Sequencing Data Analysis (2014) (52)
Noninvasive Prenatal Screening for Genetic Diseases Using Massively Parallel Sequencing of Maternal Plasma DNA. (2015) (52)
Tumor p16M is a possible marker of advanced stage in non–small cell lung cancer (2002) (50)
Cell-free DNA in maternal plasma and serum: A comparison of quantity, quality and tissue origin using genomic and epigenomic approaches. (2016) (50)
Epigenetic Tumor Markers in Plasma and Serum (2001) (49)
Detection of Plasmodium falciparum DNA in Plasma (2001) (48)
Comparison of plasma beta-globin DNA and S-100 protein concentrations in acute stroke. (2007) (47)
Investigation into the origin and tumoral mass correlation of plasma Epstein-Barr virus DNA in nasopharyngeal carcinoma. (2005) (46)
Relationship of p16 methylation status and serum alpha-fetoprotein concentration in hepatocellular carcinoma patients. (2000) (46)
Clinical applications of maternal plasma fetal DNA analysis: translating the fruits of 15 years of research. (2013) (46)
Plasma Epstein–Barr virus DNA as an archetypal circulating tumour DNA marker (2019) (45)
Noninvasive detection of F8 int22h-related inversions and sequence variants in maternal plasma of hemophilia carriers. (2017) (45)
Non-invasive prenatal testing using massively parallel sequencing of maternal plasma DNA: from molecular karyotyping to fetal whole-genome sequencing. (2013) (45)
Absence of association between angiotensin converting enzyme polymorphism and development of adult respiratory distress syndrome in patients with severe acute respiratory syndrome: a case control study (2005) (45)
Circulating DNA in Plasma and Serum: Biology, Preanalytical Issues and Diagnostic Applications (2002) (44)
Integrating post-radiotherapy plasma Epstein-Barr virus DNA and TNM stage for risk stratification of nasopharyngeal carcinoma to adjuvant therapy. (2020) (44)
Analysis of complex genetic systems by ARMS-SSCP: application to HLA genotyping. (1992) (44)
Fetal DNA in Maternal Plasma (2000) (43)
Fetomaternal cellular and plasma DNA trafficking: the Yin and the Yang. (2001) (43)
Determination of Fetal RhD Status by Maternal Plasma DNA Analysis (2000) (42)
Detection and characterization of jagged ends of double-stranded DNA in plasma (2020) (41)
Evaluation of human chorionic gonadotropin beta-subunit mRNA concentrations in maternal serum in aneuploid pregnancies: a feasibility study. (2004) (40)
Plasma β-globin DNA as a prognostic marker in chest pain patients (2006) (40)
Epigenetic-Genetic Chromosome Dosage Approach for Fetal Trisomy 21 Detection Using an Autosomal Genetic Reference Marker (2010) (40)
Next-generation sequencing of plasma/serum DNA: an emerging research and molecular diagnostic tool. (2009) (39)
Non-invasive prenatal diagnosis by massively parallel sequencing of maternal plasma DNA (2012) (39)
Tracing SARS-Coronavirus Variant with Large Genomic Deletion (2005) (39)
14 – INCORPORATION OF BIOTINYLATED dUTP (1990) (38)
Serologic antienzyme rate of Epstein-Barr virus DNase-specific neutralizing antibody segregates TNM classification in nasopharyngeal carcinoma. (2010) (37)
Detection of Mammaglobin mRNA in the Plasma of Breast Cancer Patients (2001) (37)
The biology and diagnostic applications of fetal DNA and RNA in maternal plasma. (2004) (37)
Methylation analysis of plasma DNA informs etiologies of Epstein-Barr virus-associated diseases (2019) (37)
Noninvasive prenatal testing by nanopore sequencing of maternal plasma DNA: feasibility assessment. (2015) (37)
Serial Analysis of Plasma Proteomic Signatures in Pediatric Patients with Severe Acute Respiratory Syndrome and Correlation with Viral Load (2004) (35)
Detection of restriction enzyme-digested target DNA by PCR amplification using a stem-loop primer: application to the detection of hypomethylated fetal DNA in maternal plasma. (2007) (34)
Placenta-Derived Fetal Specific mRNA Is More Readily Detectable in Maternal Plasma than in Whole Blood (2009) (34)
Detection of the tumour suppressor gene p53 in nasopharyngeal carcinoma in Hong Kong Chinese. (1994) (33)
Detection of trisomy 21 by quantitative mass spectrometric analysis of single-nucleotide polymorphisms. (2005) (33)
Reduced Plasma RNA Integrity in Nasopharyngeal Carcinoma Patients (2006) (33)
Setting up a polymerase chain reaction laboratory. (2006) (33)
A strategy for identifying circulating placental RNA markers for fetal growth assessment (2009) (32)
Genome-wide detection of cytosine methylation by single molecule real-time sequencing (2021) (32)
Serial analysis of fetal DNA concentrations in maternal plasma in late pregnancy. (2003) (31)
Cell-free DNA and RNA in plasma as new tools for molecular diagnostics (2003) (31)
Noninvasive prenatal diagnosis empowered by high‐throughput sequencing (2012) (31)
Prognostic implication of pretreatment plasma/serum concentration of Epstein-Barr virus DNA in nasopharyngeal carcinoma. (2001) (31)
The Biology and Diagnostic Applications of Plasma RNA (2004) (30)
Synthetic Peptide Studies on the Severe Acute Respiratory Syndrome (SARS) Coronavirus Spike Glycoprotein: Perspective for SARS Vaccine Development (2004) (30)
Epigenetic approaches for the detection of fetal DNA in maternal plasma (2010) (30)
Quantitative analysis of pleural fluid cell-free DNA as a tool for the classification of pleural effusions. (2003) (30)
Noninvasive Detection of Bladder Cancer by Shallow-Depth Genome-Wide Bisulfite Sequencing of Urinary Cell-Free DNA for Methylation and Copy Number Profiling. (2019) (30)
Nasopharyngeal carcinoma in situ (NPCIS)—pathologic and clinical perspectives (2002) (30)
Systematic Identification of Placental Epigenetic Signatures for the Noninvasive Prenatal Detection of Edwards Syndrome (2010) (29)
Derivation of a Prediction Rule for Posttraumatic Organ Failure Using Plasma DNA and Other Variables (2001) (28)
Plasma beta-globin DNA as a prognostic marker in chest pain patients. (2006) (28)
FetalQuantSD: accurate quantification of fetal DNA fraction by shallow-depth sequencing of maternal plasma DNA (2016) (28)
Noninvasive prenatal diagnosis of a case of Down syndrome due to robertsonian translocation by massively parallel sequencing of maternal plasma DNA. (2011) (28)
Racing Towards the Development of Diagnostics for a Novel Coronavirus (2019-nCoV) (2020) (27)
Presence of donor-derived DNA and cells in the urine of sex-mismatched hematopoietic stem cell transplant recipients: implication for the transrenal hypothesis. (2009) (27)
Prenatal sex determination from maternal peripheral blood using the polymerase chain reaction (2004) (27)
DNase1 Does Not Appear to Play a Major Role in the Fragmentation of Plasma DNA in a Knockout Mouse Model. (2018) (26)
Does centrifugation cause the ex vivo release of DNA from blood cells? (2002) (26)
Noninvasive fetal genomic, methylomic, and transcriptomic analyses using maternal plasma and clinical implications. (2015) (26)
Liver-derived cell-free nucleic acids in plasma: Biology and applications in liquid biopsies. (2019) (26)
Plasma nucleic acid analysis by massively parallel sequencing: pathological insights and diagnostic implications (2011) (25)
Proteomic analysis reveals platelet factor 4 and beta‐thromboglobulin as prognostic markers in severe acute respiratory syndrome (2012) (25)
Mass spectrometric detection of an SNP panel as an internal positive control for fetal DNA analysis in maternal plasma. (2007) (25)
Molecular analysis of circulating RNA in plasma. (2006) (25)
Circulating biomarkers in the diagnosis and management of hepatocellular carcinoma (2022) (24)
Noninvasive fetal RHD genotyping by microfluidics digital PCR using maternal plasma from two alloimmunized women with the variant RHD(IVS3+1G>A) allele (2013) (24)
Single-molecule sequencing reveals a large population of long cell-free DNA molecules in maternal plasma (2021) (24)
Application of fetal DNA in maternal plasma for noninvasive prenatal diagnosis (2002) (24)
Circulating nucleic acids as a tumor marker. (2002) (23)
Defining the immunogenetic susceptibility to primary biliary cirrhosis (1994) (23)
Fetal DNA in maternal plasma: application to non-invasive blood group genotyping of the fetus. (2001) (23)
Single-Stranded DNA Library Preparation Preferentially Enriches Short Maternal DNA in Maternal Plasma. (2017) (22)
Mass spectrometry-based detection of hemoglobin E mutation by allele-specific base extension reaction. (2007) (22)
Molecular testing of urine: catching DNA on the way out. (2000) (22)
The amplification refractory mutation system. (1998) (21)
The ins and outs of fetal DNA in maternal plasma (2003) (21)
Recent developments in fetal nucleic acids in maternal plasma: implications to noninvasive prenatal fetal blood group genotyping. (2006) (21)
Frequent p 15 Promoter Methylation in Tumor and Peripheral Blood from Hepatocellular Carcinoma Patients 1 (2000) (21)
Clinical Applications of PCR (1998) (21)
Noninvasive prenatal diagnosis in 2020. (2010) (21)
Critical assessment of four monoclonal antibodies reactive with B‐cells in formalin‐fixed paraffin‐embedded tissues (1987) (21)
Molecular epidemiology of SARS--from Amoy Gardens to Taiwan. (2003) (20)
Circulating fetal DNA in maternal plasma. (2001) (20)
Fetal Nucleic Acids in Maternal Plasma (2006) (20)
Cell-Free DNA Fragmentomics in Liquid Biopsy (2022) (20)
Noninvasive approaches to prenatal diagnosis of hemoglobinopathies using fetal DNA in maternal plasma. (2010) (19)
Noninvasive prenatal detection of fetal chromosomal aneuploidies by maternal plasma nucleic acid analysis : a review of the current state of the art (2008) (19)
Transplantation monitoring by plasma DNA sequencing. (2011) (19)
Ambient Temperature and Screening for Nasopharyngeal Cancer. (2018) (19)
Aberrant concentrations of liver-derived plasma albumin mRNA in liver pathologies. (2010) (19)
Quantitative Analysis of Cell-Free Epstein-Barr Virus DNA in Plasma of Patients with Nonnasopharyngeal Head and Neck Carcinomas (2004) (19)
Molecular diagnostics: a revolution in progress. (2015) (19)
Pregnancy-associated microRNAs in maternal plasma: a channel for fetal-maternal communication? (2010) (19)
The prognostic significance of tumor vascular invasion and its association with plasma Epstein-Barr virus DNA, tumor volume and metabolic activity in locoregionally advanced nasopharyngeal carcinoma. (2008) (18)
Circulating Fetal RNA in Maternal Plasma (2001) (18)
Fetal DNA in maternal plasma: progress through epigenetics. (2006) (18)
A new era in prenatal diagnosis: the use of cell-free fetal DNA in maternal circulation for detection of chromosomal aneuploidies. (2013) (18)
Plasma epigenetic markers for cancer detection and prenatal diagnosis. (2006) (17)
A multicenter randomized controlled trial (RCT) of adjuvant chemotherapy (CT) in nasopharyngeal carcinoma (NPC) with residual plasma EBV DNA (EBV DNA) following primary radiotherapy (RT) or chemoradiation (CRT). (2012) (17)
Prospective evaluation of plasma Epstein–Barr virus DNA clearance and fluorodeoxyglucose positron emission scan in assessing early response to chemotherapy in patients with advanced or recurrent nasopharyngeal carcinoma (2018) (16)
A microarray approach for systematic identification of placental-derived RNA markers in maternal plasma. (2008) (16)
Recent advances in the analysis of fetal nucleic acids in maternal plasma (2012) (16)
Early Detection of Cancer: Evaluation of MR Imaging Grading Systems in Patients with Suspected Nasopharyngeal Carcinoma (2020) (16)
Combined Count- and Size-Based Analysis of Maternal Plasma DNA for Noninvasive Prenatal Detection of Fetal Subchromosomal Aberrations Facilitates Elucidation of the Fetal and/or Maternal Origin of the Aberrations. (2017) (16)
COFFEE: control‐free noninvasive fetal chromosomal examination using maternal plasma DNA (2017) (16)
Topologic Analysis of Plasma Mitochondrial DNA Reveals the Coexistence of Both Linear and Circular Molecules. (2019) (16)
Effects of filtration on glyceraldehyde-3-phosphate dehydrogenase mRNA in the plasma of trauma patients and healthy individuals. (2004) (16)
SFRS7-Mediated Splicing of Tau Exon 10 Is Directly Regulated by STOX1A in Glial Cells (2011) (16)
Non-invasive prenatal diagnosis: on the horizon? (2003) (16)
Epigenetic analysis of RASSF1A gene in cell-free DNA in amniotic fluid. (2007) (16)
Characteristics of Fetal Extrachromosomal Circular DNA in Maternal Plasma: Methylation Status and Clearance. (2021) (16)
Applications of genetic-epigenetic tissue mapping for plasma DNA in prenatal testing, transplantation and oncology (2021) (15)
Technical concerns about immunoprecipitation of methylated fetal DNA for noninvasive trisomy 21 diagnosis (2012) (15)
Linkage Analysis of Maturity-Onset Diabetes of the Young With Microsatellite Polymorphisms: No Linkage to ADA or GLUT2 Genes in Two Families (1992) (15)
Serum Amyloid A Is Not Useful in the Diagnosis of Severe Acute Respiratory Syndrome (2006) (15)
Introduction to the polymerase chain reaction. (2006) (14)
Noninvasive reconstruction of placental methylome from maternal plasma DNA: Potential for prenatal testing and monitoring (2018) (14)
Use of plasma DNA to predict mortality and need for intensive care in patients with abdominal pain. (2008) (14)
Distribution of cell-free and cell-associated Epstein-Barr virus (EBV) DNA in the blood of patients with nasopharyngeal carcinoma and EBV-associated lymphoma. (2004) (14)
Jagged Ends of Urinary Cell-Free DNA: Characterization and Feasibility Assessment in Bladder Cancer Detection. (2021) (14)
Placental RNA in Maternal Plasma (2006) (14)
Gestational Age Assessment by Methylation and Size Profiling of Maternal Plasma DNA: A Feasibility Study. (2017) (14)
Genomic Sequencing of a SARS Coronavirus Isolate That Predated the Metropole Hotel Case Cluster in Hong Kong (2004) (14)
The 3a Protein of SARS-coronavirus Induces Apoptosis in Vero E6 Cells (2005) (13)
Plasma RNA Integrity Analysis (2006) (13)
Free fetal DNA in maternal circulation. (2004) (13)
Cytokine profile in fatal human immunodeficiency virus tuberculosis Epstein-Barr virus associated hemophagocytic syndrome. (2007) (13)
Noninvasive prenatal diagnosis: from dream to reality. (2015) (13)
Disruptive Innovation in Laboratory Medicine. (2015) (13)
Adiabatic compressibility of myoglobin. Effect of axial ligand and denaturation. (1986) (13)
Does percutaneous liver biopsy of hepatocellular carcinoma cause hematogenous dissemination? An in vivo study with quantitative assay of circulating tumor DNA using methylation-specific real-time polymerase chain reaction. (2004) (13)
Fetal DNA in maternal plasma/serum: the first 5 years. (2003) (13)
Prenatal assessment of fetal chromosomal and genetic disorders through maternal plasma DNA analysis (2012) (13)
New markers for cancer detection (2002) (12)
Evidence of circulating donor genetic material in bone allotransplantation. (2006) (12)
Nuclear β-catenin and Ki-67 expression in choriocarcinoma and its pre-malignant form (2006) (12)
Detrimental effect of formaldehyde on plasma RNA detection. (2005) (11)
Circulating Cell‐Free Epstein‐Barr Virus DNA Levels in Patients with EBV‐Associated Lymphoid Malignancies (2001) (11)
Comparison of protocols for extracting circulating DNA and RNA from maternal plasma. (2005) (11)
Clinical applications of plasma Epstein-Barr virus DNA analysis and protocols for the quantitative analysis of the size of circulating Epstein-Barr virus DNA. (2006) (10)
Use of a bone marrow transplantation model system to demonstrate the hematopoietic origin of plasma S100B mRNA. (2007) (10)
Cell‐free fetal DNA coming in all sizes and shapes (2021) (10)
Cell-Free DNA Fragmentomics: The New "Omics" on the Block. (2020) (10)
Noninvasive prenatal diagnosis by analysis of fetal DNA in maternal plasma. (2006) (10)
Single-molecule Sequencing Enables Long Cell-free DNA Detection and Direct Methylation Analysis for Cancer Patients. (2022) (9)
Fetal DNA in Maternal Plasma/Serum: The First 5 Years: Commentary on the article by Jimenez and Tarantal on page 18 (2003) (9)
Circulating nucleic acid analysis: diagnostic applications for acute pathologies. (2005) (9)
Germline Polymorphisms and Length of Survival of Nasopharyngeal Carcinoma: An Exome‐Wide Association Study in Multiple Cohorts (2020) (9)
Fetal mitochondrial DNA in maternal plasma in surrogate pregnancies: Detection and topology (2020) (9)
HLA typing for DR3 and DR4 using artificial restriction fragment length polymorphism PCR from archival DNA. (1995) (9)
Technical Optimization of RhD Zygosity Determination by Real‐Time Quantitative Polymerase Chain Reaction (2001) (9)
Sequencing Analysis of Plasma Epstein-Barr Virus DNA Reveals Nasopharyngeal Carcinoma-Associated Single Nucleotide Variant Profiles. (2020) (9)
Noninvasive Prenatal Diagnosis of Congenital Adrenal Hyperplasia. (2016) (9)
Fetal rhesus D mRNA is not detectable in maternal plasma. (2005) (8)
Advances in Brief Detection of Aberrant p 16 Methylation in the Plasma and Serum of Liver Cancer Patients 1 (1998) (8)
Circulating Nucleic Acids in Plasma/Serum III and Serum Proteomics Recent Developments in Fetal DNA in Maternal Plasma (2004) (8)
Towards multi-cancer screening using liquid biopsies (2020) (8)
What Is Extrachromosomal Circular DNA and What Does It Do? (2020) (8)
Reply to “STOX1 is not imprinted and is not likely to be involved in preeclampsia” (2007) (8)
Noninvasive fetal trisomy 21 detection using chromosome-selective sequencing: a variation of the molecular counting theme (2012) (8)
Nuclear β-Catenin Expression Is Rare and its Potential Association With Short Survival in Colorectal Signet-Ring Cell Carcinoma (2005) (8)
Improved risk stratification of nasopharyngeal cancer by targeted sequencing of Epstein-Barr virus DNA in post-treatment plasma. (2022) (8)
Quantitative Subtyping of Hepatitis B Virus Reveals Complex Dynamics of Ymdd Motif Mutants Development during Long-Term Lamivudine Therapy (2006) (8)
The quest for accurate measurement of fetal DNA in maternal plasma. (2011) (8)
Quantitative analysis of circulating cell‐free Epstein–Barr virus (EBV) DNA levels in patients with EBV‐associated lymphoid malignancies (2000) (8)
Noninvasive prenatal diagnosis (1998) (7)
Paraprotein Interference in an Assay of Conjugated Bilirubin (2005) (7)
Dynamic Changes of Post-Radiotherapy Plasma Epstein–Barr Virus DNA in a Randomized Trial of Adjuvant Chemotherapy Versus Observation in Nasopharyngeal Cancer (2021) (7)
Nuclear beta-catenin expression is rare and its potential association with short survival in colorectal signet-ring cell carcinoma. (2005) (7)
Genomic Sequencing of the Severe Acute Respiratory Syndrome-Coronavirus (2006) (6)
Circular RNAs as Urinary Biomarkers. (2019) (6)
Single Cell and Plasma RNA Sequencing for RNA Liquid Biopsy for Hepatocellular Carcinoma. (2021) (6)
Dinucleotide repeat polymorphism at the human GLUT2 locus. (1991) (6)
Enrichment of fetal and maternal long cell‐free DNA fragments from maternal plasma following DNA repair (2019) (6)
Effects of nucleases on cell-free extrachromosomal circular DNA (2022) (6)
Fetal nucleic acids in maternal blood: the promises (2011) (6)
Quantitative assays for telomerase: means for studying the end. (1998) (5)
The potential clinical utility of serial plasma albumin mRNA monitoring for the post-liver transplantation management. (2013) (5)
A simple and rapid approach for screening of SARS-coronavirus genotypes: an evaluation study (2005) (5)
Noninvasive Prenatal Diagnosis Using Next-Generation Sequencing (2014) (5)
Fetal nucleic acids in maternal blood: the promises. (2012) (5)
Noninvasive prenatal testing complicated by maternal malignancy: new tools for a complex problem (2016) (5)
Setting up a PCR laboratory. (1998) (5)
Molecular Diagnosis of Severe Acute Respiratory Syndrome (2006) (5)
Clinical, virologic and immunologic profiles of a young infant with severe acute respiratory syndrome. (2005) (4)
Noninvasive fetal whole-genome sequencing from maternal plasma: feasibility studies and future directions. (2013) (4)
Introduction to the polymerase chain reaction. (1998) (4)
Screening of Fetal Chromosomal Aneuploidy by Noninvasive Prenatal Testing: From Innovation to Setting Public Health Agendas to Potential Impact on Other Fields. (2019) (4)
Non-invasive prenatal diagnosis of Down's syndrome (2007) (4)
Advancing laboratory medicine through innovation: a tale of six inventors. (2012) (4)
Rapid HLA typing by multiplex amplification refractory mutation system. (1993) (4)
Proteomic profiling in SARS: diagnostic and prognostic applications. (2009) (4)
Molecular diagnostics: at the cutting edge of translational research. (2009) (4)
Screening of Fetal Chromosomal Aneuploidy by Noninvasive Prenatal Testing: From Innovation to Setting Public Health Agendas to Potential Impact on Other Fields (2020) (3)
Regulatory T-cells are required for neonatal heart regeneration (2018) (3)
Clinical applications of maternal plasma fetal DNA analysis: translating the fruits of 15 years of research (2012) (3)
Noninvasive prenatal diagnosis using cell-free fetal nucleic acids in maternal plasma (2009) (3)
Noninvasive prenatal testing: Advancing through a virtuous circle of science, technology and clinical applications (2021) (3)
Noninvasive prenatal diagnosis using fetal cells in maternal blood. (1996) (3)
Generation of labeled probes by PCR. (1998) (3)
Molecular Diagnostics: Going from Strength to Strength (2019) (3)
Molecular Testing in Laboratory Medicine: Selections from Clinical Chemistry, 1998-2001, With Annotations and Updates (2003) (3)
Linkage of maturity-onset diabetes of the young to the glucokinase gene--evidence of genetic heterogeneity. (1993) (3)
Addition of Exogenous Reporter Peptides to Serum Samples before Mass Spectrometry-Based Protease Profiling Provides Advantages over Profiling of Endogenous Peptides (2007) (3)
Investigation of the genomic representation of plasma DNA in pregnant women by comparative genomic hybridization analysis: a feasibility study. (2005) (3)
Development and validation of a risk model integrating plasma Epstein-Barr virus DNA (EBV DNA) level and TNM stage for stratification of nasopharyngeal cancer (NPC) to adjuvant therapy (2019) (3)
High-resolution analysis for urinary DNA jagged ends (2022) (3)
Fragmentomics of urinary cell-free DNA in nuclease knockout mouse models (2022) (3)
Epigenetic analysis of cell-free DNA by fragmentomic profiling (2022) (3)
A randomized trial of adjuvant chemotherapy versus observation in patients with nasopharyngeal carcinoma with detectable post-radiotherapy pEBV DNA. (2021) (2)
Nasopharyngeal carcinoma heterogeneity of DNA content identified on cytologic preparations. (2001) (2)
Comparison of Single Molecule, Real-Time Sequencing and Nanopore Sequencing for Analysis of the Size, End-Motif, and Tissue-of-Origin of Long Cell-Free DNA in Plasma. (2022) (2)
Biology and Diagnostic Applications of Cell-Free Fetal Nucleic Acids in Maternal Plasma (2010) (2)
A global view of the aspiring physician-scientist (2022) (2)
Uncertainty Intervals Based on Deleting Data Are Not Useful (2)
Fetal DNA in Maternal Plasma (2006) (1)
Recent Advances in Fetal Nucleic Acids in Maternal Plasma (2005) (1)
Circulating DNA Analysis (2004) (1)
Genetic-epigenetic tissue mapping for plasma DNA: applications in prenatal testing, transplantation and oncology (2020) (1)
Abstract 358 Comparison of circulating plasma beta-globin DNA and serum S-100 protein concentrations in patients presenting with acute stroke (2006) (1)
Jagged Ends on Multinucleosomal Cell-Free DNA Serve as a Biomarker for Nuclease Activity and Systemic Lupus Erythematosus. (2022) (1)
Circulating fetal RNA in maternal plasma: the next stage in noninvasive prenatal diagnosis. (2002) (1)
Pre-treatment plasma Epstein Barr virus -DNA (pEBV DNA) level and association with magnetic resonance imaging (MRI)-delineated tumor volume and positron-emission tomography (PET) FDG-uptake in undifferentiated nasopharyngeal carcinoma (NPC). (2004) (1)
A genome-wide search for STOX1 target genes, a transcription factor associated with Alzheimer's disease (2010) (1)
Circulating DNA analysis: protocols and clinical applications using TaqMan assays. (2004) (1)
SARS diagnosis, monitoring and prognostication by SARS-coronavirus RNA detection. (2009) (1)
Circular RNAs as Urinary Biomarkers (2019) (1)
Theranos Session at the 2016 AACC Annual Scientific Meeting & Clinical Lab Expo: Expectations, Impressions, and Takeaways. (2016) (1)
Erratum: Quantitative Analysis of Circulating Mitochondrial DNA in Plasma (Clinical Chemistry (2003) 49 (719-726)) (2004) (1)
Cancer-associated Lactobacillus iners are genetically distinct and associated with chemoradiation resistance in cervical cancer (2022) (1)
Cross-Reactivity of Three Recombinant Insulin Analogs with Five Commercial Insulin Immunoassays (1)
Molecular epidemiology of the coronavirus associated with severe acute respiratory syndrome: a review of data from the Chinese University of Hong Kong. (2004) (1)
Non-invasive prenatal diagnostics (2012) (1)
Artificial Restriction Fragment Length Polymorphism (A-RFLP) Analysis. (1998) (1)
Single-nucleotide polymorphism (SNP) of excision repair cross complementation group 1 (ERCC1) in nasopharynx cancer (NPC): A companion biomarker study to Hong Kong NPC Study Group 0502 trial (2014) (1)
Circulating Nucleic Acids for Prenatal Diagnostics (2018) (0)
Size based analysis of DNA for grading a cancer level (2013) (0)
Molecular detection and monitoring of cancer using tumor-derived DNA in plasma (2006) (0)
The recent demonstration of the presence of cell-free fetal DNA in the plasma and serum of pregnant women opens up new possibilities for noninvasive prenatal diagnosis (1999) (0)
Improved Real-Time PCR Assay for Homogeneous Multiplex Genotyping of Four CYP 2 C 9 Alleles with Hybridization Probes (2003) (0)
Advances in Brief Kinetics of Plasma Epstein-Barr Virus DNA during Radiation Therapy for Nasopharyngeal Carcinoma 1 (2000) (0)
Small Cell Lung Cancer Patients − Non Receptor Mutations in Plasma by Microfluidics Digital PCR in Single-Molecule Detection of Epidermal Growth Factor (2009) (0)
Erratum: Culture of fetal erythroid cells from maternal peripheral blood (The Lancet, July 23, 1994, p 264) (1994) (0)
Circulating Nucleic Acids: Diagnostic Potential (2004) (0)
Presence of donor-derived DNA in the plasma of sex-mismatched cardiac transplant recipients: a potential novel strategy for monitoring graft rejection (2003) (0)
QuantitativeAnalysis of theTransrenal Excretion of Circulating EBV DNA in Nasopharyngeal Carcinoma Patients (2008) (0)
Peripheral-blood cell-free Epstein-Barr viral DNA load complements clinical staging in nasopharyngeal carcinoma prognostication (2006) (0)
Prenatal detection of fetal Down's syndrome (2001) (0)
Fetal DNA in Maternal Plasma: An Amazing Two Decades (2018) (0)
Markers for prenatal diagnosis of trisomy 18 (2006) (0)
Prenatal diagnosis from maternal peripheral blood (I: Reply) (1990) (0)
Genomic Analysis of Plasma DNA in Prenatal Medicine and Beyond (2016) (0)
The diagnosis of fetal chromosomal aneuploidy using genome sequencing (2008) (0)
Erratum: Circulating placental RNA in maternal plasma is associated with a preponderance of 5′ mRNA fragments: Implications for noninvasive prenatal diagnosis and monitoring (Clinical Chemistry (2005) 51 (1789-1795)) (2006) (0)
336OBiomarker analysis of randomized controlled trial (RCT) of adjuvant chemotherapy (CT) using plasma EBV DNA to identify patients (pts) at higher risk of relapse after radiotherapy (RT) or chemoradiation (CRT) in nasopharyngeal cancer (NPC) (2017) (0)
Automated Turbidimetric Benzalkonium Chloride Method for Measurement of Protein in Urine and (2004) (0)
Abstract PL04-01: Screening for nasopharyngeal carcinoma using plasma Epstein-Barr virus DNA: Technological and clinical insights (2019) (0)
Analysis of the fetal genome from a maternal biological sample (2010) (0)
Rapid demonstration of Campylobacter in gastric biopsies using microwave irradiation. (1989) (0)
Circulating Epstein-Barr viral DNA load at mid-course of chemoradiotherapy/ radiotherapy predicts therapy outcome in advanced-stage nasopharyngeal carcinoma (2008) (0)
Editor's evaluation: Physiological TLR4 regulation in human fetal membranes as an explicative mechanism of a pathological preterm case (2021) (0)
Prospective evaluation of plasma Epstein–Barr virus DNA clearance and fluorodeoxyglucose positron emission scan in assessing early response to chemotherapy in patients with advanced or recurrent nasopharyngeal carcinoma (2018) (0)
Commentary-Fetal RNA in maternal plasma: the next stage in noninvasive prenatal diagnosis (2002) (0)
Noninvasive Detection of Bladder Cancer by Shallow-Depth Genomewide Bisulfite Sequencing of Urinary Cell-Free DNA (2019) (0)
Author response: Applications of genetic-epigenetic tissue mapping for plasma DNA in prenatal testing, transplantation and oncology (2021) (0)
Amplification from archival materials. (1998) (0)
Circulating DNA for molecular diagnostics (2020) (0)
Prenatal Diagnosis through Analysis of Intact Fetal Cells and Cell‐Free Nucleic Acids in the Maternal Circulation (2010) (0)
Non‐invasive prenatal testing of monogenic fetal characteristics by maternal plasma DNA analysis (2015) (0)
P-032: Noninvasive prenatal detection of int22h-related inversions and point mutations in maternal plasma of hemophilia carriers by single molecule counting strategies (2017) (0)
Non‐invasive detection of foetal RhD status and other genetic characteristics by circulating nucleic acids in maternal plasma (2009) (0)
Fragment Ends of Circulating Microbial DNA as Signatures for Pathogen Detection in Sepsis. (2022) (0)
PCR-Based Noninvasive Prenatal Diagnosis Using Fetal Cells in Maternal Circulation. (1998) (0)
PCR for the detection of minority DNA populations. (1998) (0)
Syncytiotrophoblast 5’-tRNA fragments are placental endocrine signals contributing to sterile inflammation in preeclampsia (2023) (0)
Discovery of Cell-Free Fetal DNA in Maternal Blood and Development of Noninvasive Prenatal Testing: 2022 Lasker-DeBakey Clinical Medical Research Award. (2022) (0)
Prognostic significance of plasma Epstein-Barr virus (EBV) DNA level in patients with locally advanced head and neck carcinoma treated with concurrent cisplatin and concomitant boost radiotherapy (CBRT). (2006) (0)
Mutational Profile of the Fetus Maternal Plasma DNA Sequencing Reveals the Genome-Wide Genetic and (2010) (0)
Fragmentation landscape of cell-free DNA revealed by deconvolutional analysis of end motifs (2023) (0)
Prognostication of survival from nasopharyngeal carcinoma by reduction of plasma Epstein-Barr viral DNA load at midpoint of radiotherapy course: A new paradigm of prognostication. (2013) (0)
Increased integrity of circulating cell-free DNA in patients suffering from nasopharyngeal carcinoma (2004) (0)
Enhanced cancer detection from cell-free DNA (2022) (0)
Principles of Molecular Biology (2012) (0)
Noninvasive Prenatal Testing for Genetic Diseases (2019) (0)
A method for assessing a disease state by means of detection of particle- and non-particle-bound nucleic acids in blood plasma and serum (2003) (0)
A prospective trial of plasma EBV DNA for the screening of nasopharyngeal carcinoma (2010) (0)
Method for detecting DNA originating from different individuals. (2002) (0)
Detection and prognostication of hepatocellular carcinoma by quantitative analysis of aberrantly methylated DNA in serum using a non-bisulfite-based method (2007) (0)
C-myc oncogene product p62 in ovarian mucinous neoplasms. (1990) (0)
A method for detecting chromosomal aneuploidies (2006) (0)
Circulating Fetal DNA/RNA in Maternal Plasma for Aneuploidy Detection (2010) (0)
Advances in Brief Circulating Epstein-Barr Virus DNA in the Serum of Patients with Gastric Carcinoma 1 (2001) (0)
2 Setting Up a Polymerase Chain Reaction Laboratory (2005) (0)
Generation of Labeled Probes by Polymerase Chain Reaction (2000) (0)
Circulating plasma beta-globin gene concentrations as a marker of stroke severity in the emergency room [Abstract] (2002) (0)
Relationship of p16 Methylation Status and Serum a -Fe-toprotein Concentration in Hepatocellular Carcinoma (2000) (0)
Methods to dns of different individuals to prove (2002) (0)
Erratum: Prenatal detection of fetal Down's syndrome (Lancet (599)) (2001) (0)
Detection of placental RNA allelic ratio in maternal plasma by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (2007) (0)
Abstract IA01: Plasma DNA-based molecular diagnostics: Fragments, circles and beyond (2020) (0)
Comparison of circulating plasma-globin DNA and serum S-100 protein concentrations in patients presenting with acute stroke (2006) (0)
Serum of Liver Cancer Patients Methylation in the Plasma and p 16 Detection of Aberrant Updated Version (1998) (0)
Serum CrossLaps Compared with Other Markers of Bone Turnover in Severely Malnourished Children (2002) (0)
Sebnif : An Integrated Bioinformatics Pipeline for the Identification of Novel Large Intergenic Noncoding RNAs ( lincRNAs )-Application in Human Skeletal Muscle Cells (2019) (0)
NON-INVASLVE PRENATAL DIAGNOSIS (1994) (0)
Absence of association between angiotensin converting enzyme polymorphisms and development of adult respiratory distress syndrome in patients with severe acute respiratory syndrome : a case control study (2005) (0)
Methods for detection of DNA derived from different individuals (2002) (0)
More on bear droppings (1992) (0)
Molecular Biological Analyses and Molecular Pathology in Clinical Chemistry (2000) (0)
Plasma Nucleic Acids (2012) (0)
An Update on Noninvasive Prenatal Diagnosis of Congenital Adrenal Hyperplasia Using Cell-free Foetal DNA in Maternal Plasma (2015) (0)

This paper list is powered by the following services:

Other Resources About Dennis Lo

What Schools Are Affiliated With Dennis Lo?

Dennis Lo is affiliated with the following schools: